Hospital Universitario 12 de Octubre

Madrid, Other 28041

0 studies enrolling now · 2 studies all time

What they study most

Hodgkin Lymphoma, Triple Negative Breast Neoplasms

Studies at this site

• Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma — Stopped early